Roundup: Inhaled Asthma Drug Stunts Growth

Asthma Drug Stunts Growth

Kids who use one inhaled steroid for asthma end up half an inch shorter. Also: Nearly half of teens with autism are bullied.

Sections:  living   
Topics:  asthma   budesonide   growth   health   height   kids   kids health   parenting   pulmicort   research   rhinocort   steroids   
RELATED ARTICLES
  • Kids allowed sips of alcohol more likely to drink later
    If you've already allowed your kids to take a little sip of your beer or wine from time to time, you probably won't be pleased when you hear the findings of a new report. More
  • Most popular baby names for 2012
    Top baby names for boys and girls in 2012. More
  • King, Messiah: New baby names suggest high hopes
    Talk about high expectations for a newborn: King and Messiah are among the fastest-rising baby names for American boys. They're just a little behind Major, the boy's name that jumped the most spots on the Social Security Administration's annual list of popular baby names. More
  • Most people aren't meeting exercise guidelines
    Most adults in the USA aren't meeting the federal physical activity recommendations for both aerobic exercise and muscle-strengthening activity, according to government statistics out today. About 79% of adults don't meet the physical activity guidelines that advise getting at least 2½ hours a week of moderate-intensity aerobic activity such as brisk walking, or one hour and 15 minutes a week of vigorous-intensity aerobic activity, such as jogging. More
BING NEWS:
  • GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With Amgen/AstraZeneca's Drug
    GSK plc (NYSE:GSK) released the headline results of the MATINEE Phase 3 trial evaluating Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5) in adults with chronic ...
    09/6/2024 - 1:04 am | View Link
  • GSK's asthma drug Nucala meets main goal in study on treating smoker's lungs
    Patients treated with Nucala and an inhaled maintenance therapy for up to 104 weeks had a lower annualised rate of moderate or severe exacerbations than those given a placebo, GSK said. COPD causes ...
    09/5/2024 - 10:17 pm | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News